KYMR – kymera therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

KYMR

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

1/28

10:00 am

kymr

Rating for KYMR

Low Report

Rating for KYMR

Report

1/28

10:00 am

kymr

Rating for KYMR

Low Report

Rating for KYMR

Report

1/15

08:02 am

kymr

Kymera Therapeutics (NASDAQ:KYMR) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $138.00 price target on the stock.

Medium Report

Kymera Therapeutics (NASDAQ:KYMR) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $138.00 price target on the stock.

Report

1/15

07:08 am

kymr

Rating for KYMR

Medium Report

Rating for KYMR

Report

1/6

08:19 am

kymr

Rating for KYMR

Low Report

Rating for KYMR

Report

1/6

08:19 am

kymr

Rating for KYMR

Low Report

Rating for KYMR

Report

1/6

07:45 am

kymr

Kymera Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research

Low Report

Kymera Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research

Report

1/6

07:45 am

kymr

Kymera Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research

Low Report

Kymera Therapeutics downgraded to Peer Perform from Outperform at Wolfe Research

Report

12/22

09:02 am

kymr

Kymera Therapeutics (NASDAQ:KYMR) had its "buy" rating reaffirmed by analysts at B. Riley.

Low Report

Kymera Therapeutics (NASDAQ:KYMR) had its "buy" rating reaffirmed by analysts at B. Riley.

Report

12/22

09:02 am

kymr

Kymera Therapeutics (NASDAQ:KYMR) had its "buy" rating reaffirmed by analysts at B. Riley.

Low Report

Kymera Therapeutics (NASDAQ:KYMR) had its "buy" rating reaffirmed by analysts at B. Riley.

Report

12/16

08:59 am

kymr

Rating for KYMR

Low Report

Rating for KYMR

Report

12/16

08:59 am

kymr

Rating for KYMR

Low Report

Rating for KYMR

Report

12/16

08:43 am

kymr

Kymera Therapeutics (NASDAQ:KYMR) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.

Low Report

Kymera Therapeutics (NASDAQ:KYMR) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.

Report

12/16

08:43 am

kymr

Kymera Therapeutics (NASDAQ:KYMR) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.

Low Report

Kymera Therapeutics (NASDAQ:KYMR) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.

Report

12/11

08:50 am

kymr

Rating for KYMR

Low Report

Rating for KYMR

Report

12/11

08:10 am

kymr

Rating for KYMR

Low Report

Rating for KYMR

Report

12/11

08:10 am

kymr

Rating for KYMR

Low Report

Rating for KYMR

Report

12/11

08:06 am

kymr

Kymera Therapeutics (NASDAQ:KYMR) had its "overweight" rating reaffirmed by analysts at Stephens.

Low Report

Kymera Therapeutics (NASDAQ:KYMR) had its "overweight" rating reaffirmed by analysts at Stephens.

Report

12/11

08:06 am

kymr

Kymera Therapeutics (NASDAQ:KYMR) had its "overweight" rating reaffirmed by analysts at Stephens.

Low Report

Kymera Therapeutics (NASDAQ:KYMR) had its "overweight" rating reaffirmed by analysts at Stephens.

Report

12/10

10:56 am

kymr

Rating for KYMR

Low Report

Rating for KYMR

Report

12/9

03:35 pm

kymr

Rating for KYMR

Low Report

Rating for KYMR

Report

12/9

03:35 pm

kymr

Rating for KYMR

Low Report

Rating for KYMR

Report

12/9

02:50 pm

kymr

Rating for KYMR

Low Report

Rating for KYMR

Report

12/9

02:50 pm

kymr

Rating for KYMR

Low Report

Rating for KYMR

Report

12/9

01:03 pm

kymr

Rating for KYMR

Low Report

Rating for KYMR

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.